BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//HealthHIV - ECPv6.18.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://healthhiv.org
X-WR-CALDESC:Events for HealthHIV
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261014T120000
DTEND;TZID=America/New_York:20261014T130000
DTSTAMP:20260904T192030Z
CREATED:20260904T192030Z
LAST-MODIFIED:20260904T192030Z
UID:10000078-1791979200-1791982800@healthhiv.org
SUMMARY:Drug Affordability in Practice: Who Saves\, Who Pays\, and What Happens to Access?
DESCRIPTION:Prescription drug affordability policies are increasingly shaping how states\, public programs\, health plans\, and other payers approach medication costs\, impacting access and affordability downstream across public and private coverage. \n\n\n\nJoin HealthHIV and its partners—AiArthritis\, the Partnership to Improve Patient Care (PIPC)\, the Partnership for Safe Medicines\, and the Rare Access Action Project (RAAP)—for a live webinar that will examine where savings are anticipated to occur\, who likely benefits\, and how payment decisions can impact: coverage\, reimbursement\, benefit design\, provider and pharmacy practices\, patient assistance programs\, and out-of-pocket costs.  \n\n\n\nThe discussion will cover: \n\n\n\n\nState Prescription Drug Affordability Board (PDAB) and Council activities and Upper Payment Limits (UPLs) in states with that authority\n\n\n\nMedicaid Pharmacy & Therapeutics (P&T) Committees and Drug Utilization Review (DUR) processes—and other broader payer and utilization-management decisions\n\n\n\nFederal Drug Pricing Policy and Medicare Maximum Fair Price (MFP) under the Inflation Reduction Act (IRA)
URL:https://healthhiv.org/event/drug-affordability-in-practice/
CATEGORIES:Advocacy,Capacity Building
ATTACH;FMTTYPE=image/jpeg:https://healthhiv.org/wp-content/uploads/2026/09/Header-ADV-DrugAffordability.jpg
LOCATION:https://healthhiv.org/event/drug-affordability-in-practice/
END:VEVENT
END:VCALENDAR